ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Quantifying the cost of measles outbreak…

Quantifying the cost of measles outbreak in the U.S. and how costs scale with outbreak size

Vaccine·August 19Open Access
ImmunologyPractice changingMeaslesSystematic ReviewVaccineMixedMeasles Vaccine

Summary

View source

What was studied

A systematic literature review of U.S. measles outbreak costs (2000–2025) across all 50 states, drawing on 19 articles and 8 gray-literature reports to estimate how costs scale with outbreak size from the medical provider and public health perspectives.

Key findings

Average cost per measles case was **$43,203.65** (range: $33,415.75 from provider perspective to $58,591.50 including public health response). Fixed costs of initiating any outbreak response were ~**$297,747** (95% CI: $4,538–$590,956), with an incremental cost of **$16,300** per additional case. Cost elasticity relative to outbreak size was **0.86** (95% CI: 0.65–1.07), meaning costs grow slightly less than proportionally with outbreak size.

Study limitations

- Only 19 articles yielded usable data, with wide confidence intervals on fixed-cost estimates, suggesting high heterogeneity across studies. - Outbreak sizes varied enormously (1–802 cases), making cost comparisons across settings difficult. - Gray literature and CDC/state reports were included, introducing potential reporting inconsistencies.

Clinical implications

Even a single measles case triggers roughly **$298,000** in fixed public health response costs before any per-case expenses — underscoring that vaccination and outbreak preparedness are far cheaper than containment. Clinicians and health systems should use the **$16,300 per-case incremental cost** figure when modeling budget impact of any uncontrolled outbreak.

Caveats

  • All cost figures are reported in nominal dollars; the paper does not specify a reference year or inflation-adjustment methodology, which may affect comparability across studies spanning 2000–2025.
  • The level of evidence (3) reflects that this is a systematic review of observational/economic outbreak data, not clinical trials; cost estimates carry wide confidence intervals and may not generalize across all U.S. jurisdictions.
  • The sample_size tag reflects the number of studies with extractable data (n=19), not a patient-level sample size — outbreak case counts ranged from 1 to 802 across included reports. Interpret numeric tags accordingly.

Related Questions

Explore related topics

What is the cost-effectiveness of measles vaccination compared to outbreak response in the US?How does measles vaccination coverage affect outbreak probability and public health costs?What are the economic impacts of the 2025 US measles outbreak on state and federal health budgets?

Publication Details

Year
2026
Journal
Vaccine
Sample Size
n=19
Source
View article
Keep scrolling
More content below.
Up Next